About Us

Columbia Laboratories' Board Approves 1-for-8 Reverse Stock Split

By: Benzinga
Columbia Laboratories, Inc. (“Columbia” or the “Company”) (NASDAQ: CBRX ) announced today that its Board of Directors (the “Board”) has set a ratio of 1-for-8 for its previously approved reverse stock split of
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.